Inicio › Contacto › Todo lo publicado en la página › Sex differences in response to angiotensin II receptor ... › Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study

Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study

La reanudación del Diplomado  Atención al Paciente Hipertenso se efectuará  el día viernes 4 de Septiembre, a las 9 am.  y que se efectuará, como está programado,  en el Anfiteatro del Hospital Calixto García. La coordinadora de este módulo de " HTA y cerebro" es la Profesora Dra.  Yamilé Valdés   con la que  puden comunicarse  por: 

Teléfono  7838 2205    o  por Email:  yamile.valdes@infomed.sld.cu

Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study

Revisiones sistematicasPor: Kunihiko Matsui, Shokei Kim-Mitsuyama, Hisao Ogawa, Tomio Jinnouchi, Hideaki Jinnouchi y Kikuo Arakawa for the OlmeSartan Calcium Antagonists Randomized (OSCAR) Study Group.  Hypertension Research (2014) 37, 526–532.

Essential hypertension is a common comorbid condition and risk factor for cardiovascular events; in addition to lifestyle modification, drug therapy is the main treatment strategy. Although there are indications for specific classes of antihypertensive drugs for particular patients, such as diuretics for hypertensive African Americans,1 there is no uniform agreement on the type of drug(s) that should be used when physicians choose an antihypertensive drug for newly diagnosed patients without specific indications for those drugs.  Recently, many evidence-based clinical practice guidelines from various clinical fields have been published to improve the quality of patient care.